EAU 2019 COVERAGE
Join GSK's Medical Experts and follow the latest scientific news about BPH from EAU 2019.
Stay tuned!
AGENDA
New insights in BPH/LUTS medical treatment - EAU guidelines update
Gravas S, et al. EAU Guidelines on the Management of Non-Neurogenic Male LUTS incl. BPO.
Available from https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/.
Last accessed March 2019.
Barbosa JA, et al. Presented at EAU 2019; poster PT191.
LTM/URO/0003/19f
Gravas S, et al. EAU Guidelines on the Management of Non-Neurogenic Male LUTS incl. BPO.
Available from https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/.
Last accessed March 2019.
LTM/URO/0003/19g
Outcomes of early vs. delayed combination medical therapy in LUTS/BPH patients with moderate to severe symptoms
Pasqua OD, et al. Presented at EAU 2019; poster PT165.
LTM/URO/0004/19
BPH and sexual function
Capogrosso P, et al. Presented at EAU 2019; poster PT-169.
Roehrborn CG, et al. BJU Int 2018; 121:647-658.
LTM/URO/0004/19b
Evaluation for LUTS in clinical practice
De Nunzio C, et al. Presented at EAU 2019; abstract 659.
Tiwari R, et al. Presented at EAU 2019; poster 671.
Gruenwald I, et al. Presented at EAU 2019; abstract 660.
LTM/URO/0004/19a
LTM/URO/0007/19
MEET THE TEAM
Prepared by GSK. For more information, adverse events reporting or product complaints contact GSK Medical Department by email fv.aecaricam@gsk.com or phone : Jamaica +1(876) 630-2074 • Trinidad +1(868) 224-5759. GSK Offices, Oceania Business Plaza Torre 1000 floor 34. Panama, Republic of Panama, C.A. All rights reserved GSK. The complete Prescribing Information and/or references are available upon request. Trademarks are owned by or licensed to the GSK group of companies. Material Exclusive for Healthcare Professionals.